COVID-19 Prevention/Treatments​​​ - Public Information

​Learn about COVID-19 Prevention and Treatments

COVID-19 treatments can help people recover and stay out of the hospital. Treatments work best when given as soon as possible after testing positive and developing symptoms. Individuals can access treatments by talking to their health care provider or by visiting a Test to Treat location​ that offers both COVID-19 testing and prescriptions for oral antiviral pills. Get the Facts on the CDPH COVID-19 Treatments webpage.


  • Vaccination: Vaccination is the best way to protect against COVID-19 and reduce the risk of hospitalization and death. There are three (3) COVID-19 vaccines available for adults, Janssen, Pfizer, and Moderna. The Pfizer and Moderna vaccines have received full FDA approval. Children ages 5 and up can receive the Pfizer vaccine to protect against COVID-19. You can find a vaccination location nearest you
  • Evusheld (Tixagevimab/Cilgavimab): Evusheld is a series of two (2) antibody shots. Evusheld is for people who are immune-compromised or who have a history of adverse reactions to vaccines. Adults and children aged 12 years or older who are eligible can receive this. Evusheld is not a treatment for COVID-19. Evusheld should not be given to people testing positive for COVID-19 or who have had a known recent exposure. Evusheld may only be prescribed for people by health care providers. Please see your primary care doctor or go to an urgent care facility for a prescription. Evusheld Fact Sheet​ 

Recent Information on COVID-19 Treatments​

​COVID-19 Therapies Test to Treat Map and Program Information Therapies Locator Map.PNG

  • A new web-based COVID-19 Test ​to Treat Locator Map is now available to make it easier to find Test to Treat locations. In the Test to Treat program, people are able to get tested and – if they are positive and treatments are appropriate for them – receive a prescription from a health care provider, and then have their prescription filled all at one location.

These products are not a substitute for vaccination against COVID-19 - learn more

These treatments require a prescription from your doctor. If you do not have a primary care doctor, please go to an urgent care. Do not approach a pharmacy without a prescription. Do not go to the emergency department of a hospital to obtain a prescription.

  • Molnupiravir: Is an oral drug for COVID-positive adults who are at high risk of developing severe disease. Treatment with Molnupiravir should begin within 5 days once symptoms begin. Molnupiravir is not for people younger than 18 years old, or people hospitalized due to COVID-19. Molnupiravir is not recommended for pregnant women. Molnupiravir Fact Sheet 
  • Paxlovid: Paxlovid is an oral drug used to treat mild-to-moderate cases of COVID-19 in adults and children 12 years old and up. Paxlovid is not meant for people hospitalized due to COVID-19. Paxlovid Fact Sheet 
  • Velkury (Remdesivir): Remdesivir a COVID-19 drug used for hospitalized people aged 12 years or older who are experiencing severe COVID-19. This drug is given through an IV and requires a doctor’s prescription. Remdesivir Fact Sheet 
  • Monoclonal Antibody Treatment (Bebtelovimab):  The monoclonal antibody treatment (Bebtelovimab) is available for adults and children aged 12 years or older who are at high risk of progressing to severe COVID-19. This treatment can be given as either a shot or IV drip and should be given within 10 days after developing symptoms. Bebtelovimab is not meant for people hospitalized due to COVID-19. Bebtelovimab Fact Sheet 

 January 2022: CDPH Available Outpatient Therapies at Each Stage


Available COVID Therapies.PNG

Text of Image​:

​SARS-CoV-2 Negative (-) Prophylaxis
SARS-CoV-2 Positive (+) Treatment ​

Not Exposed

Mild Illness or Moderate Illness​​


Treatment Options

​Long-Acting Monoclonal Antibody
  • ​Tixagevimab/cilgavimab (EVUSHELD) ​ 

Monoclonal Antibodies​​ 

  • ​Bamlanivimab/etesevimab*
  • Casirivimab/imdevimab (REGEN_COV)*

Monoclonal Antibodies​

  • Bamlanivimab/etesevimab*
  • Casirivimab/imdevimab (REGEN_COV)*​
  • Bebtelovimab​


  • Nirmatrelvir/ritonavir (PAXLOVID)
  • Molnupiravir (LAGEVRIO)
  • ​​Remdesivir (VEKLURY)​​
*Not Effective Against Omicron

COVID-19 Treatment Resource links: